GlaxoSmithKline Hints At Joining $10 Billion Auction For Pfizer Inc.'s OTC Unit

February 9, 2006 |

1 min read

Twitter
LinkedIn
Facebook
Email
Print

The drug group GlaxoSmithKline yesterday signalled its interest in bidding for Pfizer's over-the-counter health arm, set to go up for auction with a price of around $10bn (£5.75bn).

Twitter
LinkedIn
Facebook
Email
Print

Mergers & acquisitions Europe

Pfizer GlaxoSmithKline